SLC2A10 was expressed at lower levels than in normal tissue in colorectal cancer, head and neck cancer, liver cancer, and melanoma but expressed at higher levels than in normal tissue in bladder cancer, brain and central nervous system cancer, breast cancer, kidney cancer, lymphoma and sarcoma (Fig. 2A). This evidence concerns the gene SLC2A10 and colorectal cancer.